Clinical Trial Update: Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether bosentan prevents systemic cardiovascular consequences of obstructive sleep apnea; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obstructive Sleep Apnea

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Obstructive Sleep Apnea, Hypertension | Phase 2 | Status: COMPLETED